Real-time enrollment status for this advanced or metastatic adrenocortical carcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:06 AM UTC
| NCT Number | NCT07189403 |
| Recruiting Status | Recruiting |
| Condition | Advanced or Metastatic Adrenocortical Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Daiichi Sankyo |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 18, 2026: Clinical trial NCT07189403 is currently recruiting participants. This phase1 study for advanced or metastatic adrenocortical carcinoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Daiichi Sankyo. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07189403 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07189403 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.